Discovery of a SARS-CoV-2 Broadly-Acting Neutralizing Antibody with Activity against Omicron and Omicron + R346K Variants is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2022). On theSindex it has a DataRank of 0.330. It has been cited 8 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.330
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Swiss National Science Foundation
Grant: 199292
Potential use of c-Myc inhibitors as anti-viral agents against Influenza A virus
National Institutes of Health
Grant: 1R01DK130425-01
Experimental and natural SARS-CoV-2 infection of the human pancreas
National Institutes of Health
Grant: 3U54CA260560-02S2
Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses
Fields of Study
Keywords
Sustainable Development Goals